Fig. 5From: Immune cell labelling and tracking: implications for adoptive cell transfer therapiesEx vivo optical imaging (OI) study. OI of explanted tumors and organs of two representative animals at 24 h after NK92-scFv(MOC31)-zeta cell injection (upper panel) or NK-92 cell injection (lower panel). Following NK-92-scFv(MOC31)-zeta cell injection, a marked fluorescence of the tumor was noted, which was higher in intensity compared with the explanted organs. Following NK-92 cell injection, the tumor did not show an increased fluorescence. Li = liver; Lu = lungs; Sp = spleen; St = sternum; T = tumor. (adapted from Tavri et al.) (Tavri et al. 2009)Back to article page